
FibroGen
Discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs.
Market cap
$42.4m
Enterprise value
$93m
Share price
$11.13 FGEN
Authorizing premium user...
Discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs.